Blog Profile / ScienceDaily: Cancer

Filed Under:Diseases & Conditions / Cancer
Posts on Regator:1092
Posts / Week:20.3
Archived Since:September 12, 2016

Blog Post Archive

Scientists discover complex axis of immune suppression exploited by cancers

A new mechanism by which cancer cells evade destruction by the immune system has been discovered by a team of researchers. Their paper describes how immune cells known as group 2 innate lymphoid cells (ILC2s) are recruited by leukemic cells to suppress an essential anticancer immune response.

Treatment-resistant melanoma may be vulnerable to a drug holiday, study finds

A new study has uncovered the mechanisms by which treatment-resistant melanoma become vulnerable to cessation of a class of drugs called MAP kinase (MAPK)-targeted inhibitors. By identifying these mechanisms, the scientists discovered...Show More Summary

'Language of stem cells' discovered

Stem cells control the cells around them, inducing them to perform specific functions. This phenomenon of the "language of stem cells", which has now been discovered for the very first time, report investigators.

How patients are likely to respond to DNA drugs

Research could lead to improvements in treating patients with diseases caused by mutations in genes, such as cancer, cystic fibrosis and potentially up to 6,000 other inherited conditions.

MicroRNA helps cancer evade immune system

Researchers have discovered how oxygen-deprived tumors survive body's immune response, explains a new report.

How bacteria hinder chemotherapy

Scientists have found bacteria in pancreatic tumors that metabolize a common drug, explains a new report.

Altitude training for cancer-fighting cells

Oxygen starvation could toughen up immune T cells for cancer immunotherapy, reports a team of investigators.

Sugary secrets of a cancer-related protein

The proteins in human cells are extensively decorated with different types of sugars, a phenomenon called glycosylation. These modifications greatly increase the diversity of protein structure and function, affecting how proteins fold, how they behave, and where they go in cells. Show More Summary

Low-level radiation exposure less harmful to health than other modern lifestyle risks

Low-level radiation exposure poses less of a health risk than other lifestyle threats, such as smoking, obesity and air pollution, according to new research. Human populations have always been exposed to ionizing radiation, and more so in modern life. Show More Summary

New inhibitor brings new hope for aggressive triple receptor-negative breast cancer

Researchers found a possible new treatment for aggressive triple receptor-negative breast cancer.

Chimera viruses can help the fight against lymphomas

Researchers have created a chimera virus that allows the study of molecules to treat cancers caused by human herpes virus infection in mice models of disease.

'Internal clock' found within live human cells

An internal clock has been discovered within live human cells, a finding that creates new opportunities for understanding the building blocks of life and the onset of disease.

'Epigenetic' changes from cigarette smoke may be first step in lung cancer development

Scientists say they have preliminary evidence in laboratory-grown, human airway cells that a condensed form of cigarette smoke triggers so-called 'epigenetic' changes in the cells consistent with the earliest steps toward lung cancer development.

Outside-in reprogramming: Antibody study suggests a better way to make stem cells

A new approach to the 'reprogramming' of ordinary adult cells into stem cells has been uncovered by scientists.

What mediates the beneficial effects of exercise on breast cancer outcomes?

The ability of serum obtained from women with breast cancer immediately after finishing two hours of moderate to intense exercise to prevent the growth and survival of breast cancer cells lines in vitro and in mice was attributable, at least in part, to epinephrine activation of the Hippo signaling pathway.

Comparing cancer drug effectiveness from cells to mice to man

Researchers who studied the cancer drug gemcitabine in cell culture, mouse models and humans have shown that the drug, at administered (tolerated) dose, arrests cell growth during cancer progression. This information can lead to better understanding how gemcitabine can be combined with other drugs at identified phases to more effectively treat cancer.

Abdominal fat a key cancer driver for postmenopausal women

Body fat distribution in the trunk is more important than body weight when it comes to cancer risk in postmenopausal women, according to a new study.

Human papillomavirus 16 infections may pose variable cancer risk

Human papillomavirus 16 accounts for about half of all cervical cancers, but researchers have found that not all infections are equal. An analysis of the HPV16 genome from 5,570 human cell and tissue samples revealed that the virus actually...Show More Summary

Blood tumor markers may warn when lung cancer patients are progressing

A new study suggests that rather than screening for disease, blood tumor markers could be useful in monitoring therapeutic outcomes in those with already established disease.

Recurrence of prostate cancer could be reduced thanks to exciting new discovery

Groundbreaking research could reduce the recurrence of prostate cancer in males, a new study reports.

Copyright © 2015 Regator, LLC